Group One Trading’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1 | Sell |
1
-18
| -95% | -$18 | ﹤0.01% | 1998 |
|
2025
Q1 | $26 | Buy |
19
+1
| +6% | +$1 | ﹤0.01% | 1881 |
|
2024
Q4 | $98 | Hold |
18
| – | – | ﹤0.01% | 1937 |
|
2024
Q3 | $129 | Hold |
18
| – | – | ﹤0.01% | 1611 |
|
2024
Q2 | $169 | Hold |
18
| – | – | ﹤0.01% | 1634 |
|
2024
Q1 | $273 | Hold |
18
| – | – | ﹤0.01% | 1627 |
|
2023
Q4 | $355 | Hold |
18
| – | – | ﹤0.01% | 1734 |
|
2023
Q3 | $631 | Hold |
18
| – | – | ﹤0.01% | 1730 |
|
2023
Q2 | $920 | Hold |
18
| – | – | ﹤0.01% | 1598 |
|
2023
Q1 | $459 | Hold |
18
| – | – | ﹤0.01% | 1681 |
|
2022
Q4 | $560 | Sell |
18
-61
| -77% | -$1.9K | ﹤0.01% | 1763 |
|
2022
Q3 | $5K | Hold |
79
| – | – | ﹤0.01% | 1688 |
|
2022
Q2 | $13K | Buy |
79
+9
| +13% | +$1.48K | ﹤0.01% | 1602 |
|
2022
Q1 | $17K | Hold |
70
| – | – | ﹤0.01% | 1659 |
|
2021
Q4 | $49K | Buy |
+70
| New | +$49K | ﹤0.01% | 1579 |
|